BRPI0413881A - composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto - Google Patents

composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto

Info

Publication number
BRPI0413881A
BRPI0413881A BRPI0413881-3A BRPI0413881A BRPI0413881A BR PI0413881 A BRPI0413881 A BR PI0413881A BR PI0413881 A BRPI0413881 A BR PI0413881A BR PI0413881 A BRPI0413881 A BR PI0413881A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
taste masking
masking coating
anticonvulsant
core particles
Prior art date
Application number
BRPI0413881-3A
Other languages
English (en)
Inventor
Arti Potdar
Manjurahamad Momin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BRPI0413881A publication Critical patent/BRPI0413881A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA COMPREENDENDO ANTICONVULSIVANTE COM REVESTIMENTO DE MASCARAMENTO DE GOSTO". A presente invenção refere-se a uma composição farmacêutica na forma de partículas de núcleo revestidas compreendendo uma droga anticonvulsivante que pode ser borrifada sobre o alimento, em que as ditas partículas de núcleo são revestidas com um revestimento de mascaramento de gosto que é menos que 7% em peso da composição farmacêutica.
BRPI0413881-3A 2003-08-28 2004-08-27 composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto BRPI0413881A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03468006 2003-08-28
PCT/EP2004/009588 WO2005020961A1 (en) 2003-08-28 2004-08-27 Pharmaceutical composition comprising anticonvulsant with taste mask coating

Publications (1)

Publication Number Publication Date
BRPI0413881A true BRPI0413881A (pt) 2006-10-24

Family

ID=34259309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413881-3A BRPI0413881A (pt) 2003-08-28 2004-08-27 composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto

Country Status (5)

Country Link
US (1) US20070154550A1 (pt)
EP (1) EP1673064A1 (pt)
BR (1) BRPI0413881A (pt)
NO (1) NO20061407L (pt)
WO (1) WO2005020961A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US7470791B2 (en) 2003-03-10 2008-12-30 Nycomed Gmbh Process for the preparation of roflumilast
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
DE202005016250U1 (de) * 2005-10-17 2006-01-26 Helm Ag Topiramat und pharmazeutische Formulierungen davon
CN103316026B (zh) * 2012-03-23 2016-05-11 中国人民解放军军事医学科学院毒物药物研究所 含芬特明和托吡酯的联合产品及其制备方法
JP6055076B2 (ja) * 2012-03-23 2016-12-27 インスティテュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー．エル．エー．チャイナ シネフリン及びトピラマートを含む組み合わせ製品
CN102579367B (zh) * 2012-03-23 2014-03-12 中国人民解放军军事医学科学院毒物药物研究所 托吡酯缓释药物组合物、其制备方法及用途
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
EP2968181B1 (en) 2013-03-15 2019-10-16 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate
JP6463333B2 (ja) 2013-03-15 2019-01-30 アプレシア・ファーマスーティカルズ・カンパニー オキシカルバゼピンの急速分散性の剤形
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US104142A (en) * 1870-06-14 Improvement in adjustable sheds
US64563A (en) * 1867-05-07 Edward phife
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
DE3438291A1 (de) * 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5578316A (en) * 1992-06-04 1996-11-26 Smithkline Beecham Corporation Palatable pharmaceutical compositions
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
ATE452637T1 (de) * 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält

Also Published As

Publication number Publication date
US20070154550A1 (en) 2007-07-05
EP1673064A1 (en) 2006-06-28
NO20061407L (no) 2006-08-25
WO2005020961A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
BRPI0413881A (pt) composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
WO2008015249A3 (en) Cosmetic or pharmaceutical composition containing hyaluronic acid
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
BRPI0417947A (pt) composto, composição farmacêutica, fabricação de um medicamento para o uso no tratamento e/ou prevenção de um metabólico distúrbio, e, formulação farmacêutica
BR112013003581A2 (pt) formulação farmacêutica ou nutracêutica gastro resistente que compreende um ou mais sais do ácido algínico
RS51808B (en) PROCEDURES FOR THE APPLICATION OF AMINOPYRIDINE COMPOUNDS WITH LONG TERM RELEASE
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
BRPI0717907A2 (pt) "composto, composição farmacêutica, métodos para tratar um câncer, para inbir ou modular a atividade da lipídeo quinase, processo para a produçãoo de uma composição farmacêutica, uso de um composto e kit"
BRPI0705546A (pt) composições de tratamento oral
BR0315665A (pt) Antagonistas de cgrp selecionados, processos para preparação dos mesmos, bem como uso dos mesmos como medicamento
AR048456A2 (es) Composicion farmaceutica de topiramato
BRPI0719488A2 (pt) "composição, processo de preparação da composição, uso de uma composição e uso cosmético de uma composição"
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
BR0202491A (pt) Forma de dosagem de núcleo macio, de revestimento frágil
BRPI0916069A2 (pt) "composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição"
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
BRPI0617045B8 (pt) composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição
BRPI0815455C1 (pt) compostos derivados de n-fenilacetamida, composição farmacêutica, composição cosmética, uso cosmético de uma composição, e usos de um composto do mesmo
BRPI0410044B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
SV2006002122A (es) Prodrogas de estriol y estetrol ref. p-sv-78.343/msu
BRPI0815531A2 (pt) "compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição e uso de um composto"
BR112015014092A2 (pt) administração oral transmucosal de acetato de glatirâmer
ITMI20062254A1 (it) Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. A61K 31/7048, A61K 9/16, A61K 9/50, A61P 25/08

Ipc: A61K 31/7048 (2011.01), A61K 9/16 (2011.01), A61K

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2268 DE 24/06/2014.